.

[. @AvactaDx]

@Baylism @ThePandemicInst Thanks Professor Baylis! And thanks to @ESCVirology for letting us share the talk. I hope everyone finds it as interesting as we did.

[. @AvactaDx]

@DomPosen @avacta Thanks @DomPosen for using our test and providing us with this feedback. We are constantly monitoring the usability and design of the product and will feed this in as part of that.

[. @AvactaDx]

@Billswill5 Correct @Billswill5. This channel is not aimed at investors and we cannot respond to investor enquires here. This account is to communicate @AvactaDx product updates to customers and distributors. Investors can follow @avacta for information on Avacta Group plc #AVCT

[. @AvactaDx]

@MalcolmPenn6 The @AvactaDx Industry Symposium has been recorded and will be available to #ESCV2021 registered delegates for 3 months after the conference. Poster abstracts will be available in due course.

[. @AvactaDx]

@pharvey600 To make a commercial enquiry about purchasing the test, please contact us and provide the details of how many units you are interested in. Currently our test is approved for professional use only. https://t.co/HgzEyJmYuw

[. @AvactaDx]

@CraigMc18356919 We are working closely with @Medusa19, with the joint goal of an approved lateral flow self test for SARS-CoV-2. Currently our test is approved for professional use only.